DeGregori, James;
Pharoah, Paul;
Sasieni, Peter;
Swanton, Charles;
(2020)
Cancer Screening, Surrogates of Survival, and the Soma.
Cancer Cell
, 38
(4)
pp. 433-437.
10.1016/j.ccell.2020.09.003.
Preview |
PDF
DeGregori-J-2020-Cell.pdf - Accepted Version Download (356kB) | Preview |
Abstract
Screening leads to meaningful reductions in deaths from cancers. However, reductions in all-cause mortality (ACM) are harder to demonstrate. Failure to demonstrate ACM benefit should not diminish advances in cancer screening. We consider how co-morbidities related to an aging and damaged soma can hinder achievement of ACM benefit.
| Type: | Article |
|---|---|
| Title: | Cancer Screening, Surrogates of Survival, and the Soma |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ccell.2020.09.003 |
| Publisher version: | https://doi.org/10.1016/j.ccell.2020.09.003 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Oncology, Cell Biology, MORTALITY, DISEASE, RISK |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10150762 |
Archive Staff Only
 |
View Item |
